share email print adminAuthor website Articles, Myoblast therapy 15 February, 2005 Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Journal CirculationPMID 112(12):1748-55Year 2005Dib N, Michler RE, Pagani FD, et al.